A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia

This study is testing a long-term use of a medication called SEP-363856 (also known as ulotaront) in Japanese people with schizophrenia. Researchers want to see if the drug is safe and effective when taken over a longer period of time. **You may be eligible if...** - You are Japanese, age 18 or older - You have been diagnosed with schizophrenia - Your symptoms have been stable for at least 8 weeks - Your symptom scores are at a mild-to-moderate level (PANSS ≤ 80, CGI-S ≤ 4) - Your antipsychotic medication has not changed in the past 6 weeks **You may NOT be eligible if...** - You were hospitalized for psychiatric reasons in the past 8 weeks - You have tried two or more antipsychotic medications without improvement - You have ever been treated with clozapine - You are unwilling to follow the medication rules in the study Talk to your doctor to see if this trial is right for you.